IE902299L - Derivatized DTPA complexes, pharmaceutical agents containing¹these compounds, their use and processes for their¹production - Google Patents

Derivatized DTPA complexes, pharmaceutical agents containing¹these compounds, their use and processes for their¹production

Info

Publication number
IE902299L
IE902299L IE902299A IE229990A IE902299L IE 902299 L IE902299 L IE 902299L IE 902299 A IE902299 A IE 902299A IE 229990 A IE229990 A IE 229990A IE 902299 L IE902299 L IE 902299L
Authority
IE
Ireland
Prior art keywords
represent
hydrogen atom
compounds
pharmaceutical agents
denote
Prior art date
Application number
IE902299A
Other versions
IE902299A1 (en
IE65676B1 (en
Original Assignee
Longcrest Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6384290&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IE902299(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Longcrest Ltd filed Critical Longcrest Ltd
Publication of IE902299L publication Critical patent/IE902299L/en
Publication of IE902299A1 publication Critical patent/IE902299A1/en
Publication of IE65676B1 publication Critical patent/IE65676B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/16Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02Iron compounds
    • C07F15/025Iron compounds without a metal-carbon linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/003Compounds containing elements of Groups 3 or 13 of the Periodic Table without C-Metal linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/94Bismuth compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Compounds of the general formula <IMAGE> in which Z<1> and Z<2> each represent a hydrogen atom or the radical -(CH2)m-(C6H4)q-(O)k-(CH2)n(C6H4) l-(O)r-R, in which m and n denote the figures 0 - 20, k, l, q and r denote the figures 0 and 1 and R denotes a hydrogen atom, an unsubstituted or OR<1>-substituted C1-C6-alkyl radical or a CH2COOR<1> group where R<1> denotes a hydrogen atom, a C1-C6-alkyl radical or a benzyl group, X represents a hydrogen atom and/or a metal ion equivalent of an element of atomic number 21 - 29, 42, 44 or 57 - 83, with the proviso that at least two of the substituents X represent a metal ion equivalent in which one of the substituents Z<1> and Z<2> represents a hydrogen atom and the other does not represent a hydrogen atom, in which - if n and l each represent the figure 0 - k and r do not simultaneously each denote the figure 1, in which Z<1> or Z<2> do not represent -CH2-C6H4-O-CH2-COOCH2C6H5 or CH2-C6H4-O-(CH2)5-COOCH2C6H5 and in which -(O)r-R does not represent -OH, and their salts with inorganic and/or organic bases, amino acids or amino acid amides, are useful pharmaceutical agents. [EP0405704A2]
IE229990A 1989-06-30 1990-06-26 Derivatized DTPA complexes pharmaceutical agents containing these compounds their use and processes for their production IE65676B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3922005A DE3922005A1 (en) 1989-06-30 1989-06-30 DERIVATIVED DTPA COMPLEXES, PHARMACEUTICAL AGENTS CONTAINING THESE COMPOUNDS, THEIR USE AND METHOD FOR THE PRODUCTION THEREOF

Publications (3)

Publication Number Publication Date
IE902299L true IE902299L (en) 1990-12-30
IE902299A1 IE902299A1 (en) 1991-01-16
IE65676B1 IE65676B1 (en) 1995-11-15

Family

ID=6384290

Family Applications (1)

Application Number Title Priority Date Filing Date
IE229990A IE65676B1 (en) 1989-06-30 1990-06-26 Derivatized DTPA complexes pharmaceutical agents containing these compounds their use and processes for their production

Country Status (23)

Country Link
EP (1) EP0405704B1 (en)
JP (1) JP2603357B2 (en)
KR (1) KR100190808B1 (en)
AT (1) ATE115546T1 (en)
AU (1) AU637111B2 (en)
CA (1) CA2020142C (en)
CZ (1) CZ277926B6 (en)
DD (1) DD296276B5 (en)
DE (3) DE3922005A1 (en)
DK (1) DK0405704T3 (en)
ES (1) ES2066113T3 (en)
FI (1) FI102168B1 (en)
HU (1) HU210208B (en)
IE (1) IE65676B1 (en)
IL (1) IL94818A (en)
NL (1) NL300182I2 (en)
NO (2) NO179203C (en)
NZ (1) NZ234295A (en)
PT (1) PT94541B (en)
RU (1) RU2086554C1 (en)
TW (1) TW219356B (en)
UA (1) UA27275C2 (en)
ZA (1) ZA905129B (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4011684A1 (en) * 1990-04-06 1991-10-10 Schering Ag DTPA MONOAMIDES, PHARMACEUTICAL AGENTS CONTAINING THESE COMPOUNDS, THEIR USE AND METHOD FOR THE PRODUCTION THEREOF
DE4302287A1 (en) * 1993-01-25 1994-07-28 Schering Ag Derivatized DTPA complexes, pharmaceutical compositions containing these compounds, their use and processes for their preparation
DE4302289A1 (en) * 1993-01-25 1994-07-28 Schering Ag Process for the preparation of C-substituted diethylenetriamines
DE4341724A1 (en) * 1993-12-03 1995-06-08 Schering Ag Pharmaceutical compositions containing haloaryl-substituted metal complexes, their use in diagnostics, and methods for producing the complexes and compositions
US5582814A (en) * 1994-04-15 1996-12-10 Metasyn, Inc. 1-(p-n-butylbenzyl) DTPA for magnetic resonance imaging
US5672335A (en) * 1994-11-30 1997-09-30 Schering Aktiengesellschaft Use of metal complexes as liver and gallbladder X-ray diagnostic agents
AU4173896A (en) * 1994-11-30 1996-06-19 Schering Aktiengesellschaft Use of chelate compounds as diagnostic agents in the x-ray examination of liver and bile ducts
TW319763B (en) 1995-02-01 1997-11-11 Epix Medical Inc
DE19606326A1 (en) * 1995-02-09 1996-08-22 Schering Ag Contrast agent-containing liposome formulation and its use for in vivo diagnostics, in particular for the representation of the intravasal space
DE19507820A1 (en) * 1995-02-21 1996-08-22 Schering Ag Novel substituted DTPA derivatives, their metal complexes, pharmaceutical compositions containing these complexes, their use in diagnostics, and methods for producing the complexes and compositions
JP2759627B2 (en) * 1995-07-21 1998-05-28 東北大学長 Non-ester bondable DTPA derivative and method for producing the same
DE19641197C2 (en) * 1996-09-24 1999-02-18 Schering Ag Ion pairs and their use as contrast agents
DE19646762B4 (en) * 1996-11-04 2004-05-13 Schering Ag Use of metal compounds for the production of agents for radiotherapy of tumors
DE19712012A1 (en) * 1997-03-13 1998-09-24 Schering Ag Ethoxy:benzyl-di:ethylene tri:amine penta:acetic acid preparation
US6495118B1 (en) 1997-09-26 2002-12-17 Schering Aktiengesellschaft Lipophilic metal complexes for necrosis and infarction imaging
DE19744004C1 (en) * 1997-09-26 1999-07-22 Schering Ag Lipophilic metal complexes for necrosis and infarct imaging
US6534040B2 (en) * 1999-12-23 2003-03-18 Health Research, Inc. Chlorin and bacteriochlorin-based aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
FR2867473B1 (en) 2004-03-12 2006-06-23 Guerbet Sa PORPHYRINE COMPOUND AND HIGH FIELD USE IN MRI
KR100749087B1 (en) * 2006-06-02 2007-08-14 경북대학교 산학협력단 Novel DTPA-bis-amide Ligands and Gadolinium Complexes Associated With They
SE533165C2 (en) * 2008-06-13 2010-07-13 Chemseq Internat Ab Chemical and process for the complex bonding of metal ions, which are at least divalent
EP2338874A1 (en) * 2009-12-16 2011-06-29 Bracco Imaging S.p.A Process for the preparation of chelated compounds
DE102010023890A1 (en) 2010-06-11 2011-12-15 Bayer Schering Pharma Aktiengesellschaft Preparing crystalline 3,6,9-triaza-3,6,9-tris(carboxymethyl)-4-(ethoxybenzyl)-undecanedioic acid comprises hydrolyzing 3,6,9-triaza-3,6,9-tris(tert-butoxy-carbonylmethyl)-4-(ethoxybenzyl)-undecanedioic acid-ditert-butylester and acidifying
US20130158241A1 (en) 2010-06-11 2013-06-20 Bayer Intellectual Property Gmbh Process for Preparing Crystalline 3,6,9-triaza-3,6,9-tris(carboxymethyl)-4-(4-ethoxybenzyl)undecanedioic Acid and Use for Production of Primovist®
CN104761461A (en) * 2014-09-09 2015-07-08 山东富创医药科技有限公司 Preparation method of novel gadoxetate disodium intermediate
EP3464237B1 (en) * 2016-05-30 2023-12-20 Biophore India Pharmaceuticals Pvt. Ltd. Novel process for the preparation of gadolinium complex of (4s)-4-(4-ethoxybenzyl)-3,6,9-tris(carboxylatomethyl)-3,6,9- triazaundecanedioic acid disodium (gadoxetate disodium)
JP6867639B2 (en) * 2016-10-11 2021-05-12 学校法人 聖マリアンナ医科大学 Combined nonionic iodine contrast agent
EP4059925A1 (en) 2021-03-15 2022-09-21 Bayer Aktiengesellschaft New contrast agent for use in magnetic resonance imaging
EP4335840A1 (en) 2022-09-09 2024-03-13 Bayer Aktiengesellschaft New contrast agents for use in diagnostic imaging
EP4335462A1 (en) 2022-09-09 2024-03-13 Bayer AG Contrast agents for use in diagnostic computed tomography imaging

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL194579C (en) * 1983-01-21 2002-08-05 Schering Ag Diagnostic.
US4672028A (en) * 1984-05-23 1987-06-09 Icn Micromedic Systems, Inc. Compositions and method for simultaneous multiple array of analytes using radioisotope chelate labels
US4824986A (en) * 1985-04-26 1989-04-25 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Metal chelate protein conjugate
IL83966A (en) * 1986-09-26 1992-03-29 Schering Ag Amides of aminopolycarboxylic acids and pharmaceutical compositions containing them
DE3710730A1 (en) * 1987-03-31 1988-10-20 Schering Ag SUBSTITUTED COMPLEX ILLUMINATORS, COMPLEX AND COMPLEX SALTS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THEM
JP2833766B2 (en) * 1987-07-16 1998-12-09 ニユコメド・アクシエセルカペト Aminopolycarboxylic acid and its derivatives
AU617338B2 (en) * 1987-07-16 1991-11-28 Nycomed As Aminopolycarboxylic acids and derivatives thereof
DE3728525A1 (en) * 1987-08-24 1989-03-16 Schering Ag MULTI-CORE SUBSTITUTED COMPLEX ILLUMINATORS, COMPLEX AND COMPLEX SALTS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THEM

Also Published As

Publication number Publication date
CS9003174A2 (en) 1991-11-12
IE902299A1 (en) 1991-01-16
UA27275C2 (en) 2000-09-15
CA2020142A1 (en) 1990-12-31
AU637111B2 (en) 1993-05-20
EP0405704B1 (en) 1994-12-14
ZA905129B (en) 1991-04-24
PT94541A (en) 1991-02-08
JPH03215457A (en) 1991-09-20
KR910000134A (en) 1991-01-29
ES2066113T3 (en) 1995-03-01
NO179203C (en) 1996-08-28
CZ277926B6 (en) 1993-06-16
DE122004000051I2 (en) 2011-12-29
NL300182I1 (en) 2005-06-01
HUT54622A (en) 1991-03-28
IE65676B1 (en) 1995-11-15
CA2020142C (en) 2001-04-17
IL94818A0 (en) 1991-04-15
IL94818A (en) 1996-05-14
DE122004000051I1 (en) 2005-04-21
EP0405704A2 (en) 1991-01-02
NO902925L (en) 1991-01-02
NO902925D0 (en) 1990-06-29
FI903295A0 (en) 1990-06-29
FI102168B (en) 1998-10-30
ATE115546T1 (en) 1994-12-15
DK0405704T3 (en) 1995-02-20
AU5802490A (en) 1991-01-03
NO2005013I2 (en) 2006-06-19
HU904040D0 (en) 1990-12-28
DD296276B5 (en) 1995-11-02
DE59007987D1 (en) 1995-02-02
PT94541B (en) 1997-02-28
DE3922005A1 (en) 1991-01-10
HU210208B (en) 1995-02-28
EP0405704A3 (en) 1991-03-27
KR100190808B1 (en) 1999-06-01
JP2603357B2 (en) 1997-04-23
NZ234295A (en) 1993-02-25
RU2086554C1 (en) 1997-08-10
HK1002810A1 (en) 1998-09-18
NL300182I2 (en) 2005-08-01
FI102168B1 (en) 1998-10-30
NO179203B (en) 1996-05-20
TW219356B (en) 1994-01-21

Similar Documents

Publication Publication Date Title
IE902299L (en) Derivatized DTPA complexes, pharmaceutical agents containing¹these compounds, their use and processes for their¹production
CA2169194A1 (en) Substituted azadioxacycloalkenes and their use as fungicides
CA2195964A1 (en) Pesticide
ZA903605B (en) Fungicidal agents,and substituted amino acid amide derivatives and their preparation
CA2039218A1 (en) Boronic acid adducts of metal dioxime complexes useful in labelling proteins and other amine-containing compounds
CA2010859A1 (en) Corrosion inhibitor and method of use
NO970055D0 (en) Cascade Polymer Complexes, Methods of Preparation thereof, and Pharmaceutical Agents Containing Such
AU4548189A (en) Glycosphingolipids with a group capable of coupling in the sphingoid portion, the preparation and use thereof
CA2320706A1 (en) 20-hete antagonists and agonists
ES2059669T3 (en) A METHOD TO PREPARE (2R, 3S, 4S) -ALPHA- (CARBOXICICLOPROPIL) -GLYCINE.
CA2234480A1 (en) Colchicine and thiocolchicine derivatives with antiinflammatory and muscle relaxant activities
DE69502448D1 (en) (S, S) -ethylenediamine-N, N&#39;-disuccinic acid-iron (III) ammonium complex salt and process for their preparation
EP0811245A4 (en) MICROELECTRONIC ASSEMBLIES INCLUDING CONDUCTIVE FILMS FOLLOWING THE Z-AXIS
MTP1014B (en) Substituted aminopropionamides,a process for their preparation,agents containing them,and their use,and new intermediates produced in the preparation (hoe 861f 302)
AU2958789A (en) Amino acid amides with a psychotropic action, processes for their preparation, agents containing them and their use
IT1149282B (en) PROCEDURE FOR OBTAINING MEDIUM-CARBON MANGANESE ALLOYS
DE69002478D1 (en) N-SUBSTITUTED 3 - ((2,3-DIMETHYLMALEIMIDO) AMINO) BENZOLSULFONAMIDE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND HERBICIDAL COMPOSITIONS.
GB8823776D0 (en) New 2-methoxycarbonyl sustituted n n&#39;-di-(trimethoxybenzoyl)piperazines
CS348789A2 (en) Jig for screwdrivers&#39; working parts grinding-in
MY105072A (en) Substituted alkenes, processes for their preparation and their use as pesticides.
FR11C0012I2 (en) METHOD FOR PREPARING A C1-ESTERASE INHIBITOR CONCENTRATE (C1-INH), AND CONCENTRATE OBTAINED, FOR THERAPEUTIC USE
IT8984989A0 (en) EQUIPMENT PARTICULARLY SUITABLE FOR BAGKING CLOTHING IN WRAPPING, FILM, HEAT-SEALABLE
ATE84520T1 (en) (+-)- OR (+)-1-(2-N-SUBSTITUTED AMINOAETHYL)1-METHYL-7-METHOXY-1,2,3,4-TETRAHYDRONAPTHALEN AND PROCESS FOR PRODUCTION THEREOF.
ITFI910158U1 (en) PRISMATIC AND REDUCED CAPACITY SECTION TEST, FOR QUANTITATIVE ANALYSIS OF CLINICAL CHEMISTRY CARRIED OUT PHOTOMETRICALLY

Legal Events

Date Code Title Description
SPCF Request for grant of supplementary protection certificate

Free format text: SPC010/2005, 20050324

Spc suppl protection certif: SPC010/2005

Filing date: 20050324

SPCG Supplementary protection certificate granted

Free format text: SPC010/2005: 20060316, EXPIRES: 20150625

Spc suppl protection certif: SPC010/2005

Filing date: 20060316

Expiry date: 20150625

MK9A Patent expired